Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Maude Bouscambert‐Duchamp et al.|The Lancet Infectious Diseases|2021Cited by 344
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Matthias Briel, Lori E. Dodd et al.|The Lancet Respiratory Medicine|2023Cited by 124
Automated bioinformatic pipeline for unbiased detection of tuberculosis transmission clusters: Real-time impact and retrospective insightsCharlotte Genestet, Oana Dumitrescu, Quentin Testard et al.|medRxiv|2026Cited by 0
Automated Bioinformatic Pipeline for Unbiased Detection of Tuberculosis Transmission Clusters: Real-Time Impact and Retrospective InsightsCharlotte Genestet, Oana Dumitrescu, Quentin Testard et al.|SSRN Electronic Journal|2026Cited by 0